CLOs on the Move

Portola

www.portola.com

 
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.portola.com
  • 270 E. Grand Avenue
    South San Francisco, CA USA 94080
  • Phone: 650.246.7000

Executives

Name Title Contact Details
Michael Ouimette
Vice President and Assistant Secretary, Legal Profile
Michael Ouimette
Executive Director and Assistant Corporate Secretary Profile
John Moriarty
Executive Vice President and General Counsel Profile
John Moriarty
Executive Vice President, General Counsel and Secretary Profile

Similar Companies

Spectrum Athletic Clubs

Spectrum Athletic Clubs is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.

Outcome Resources

Outcome Resources is a Rocklin, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United Pharmacists Enterprises

United Pharmacists Enterprises Ltd is a Saskatoon, SK-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Reckitt Benckiser

We protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. Our products reach millions of people every day, as we fight to improve global access to the highest quality hygiene, wellness and nourishment. We`re a growing community of 40,000+ diverse, talented entrepreneurs, and the driving force behind some of the world`s most loved and trusted brands. Our portfolio includes household names such as Enfamil, Nutramigen, Nurofen, Strepsils, Gaviscon, Mucinex, Durex, Lysol, Dettol, Harpic, Cillit Bang, Finish and Vanish. Hygiene, Health and Nutrition are the focus areas of our business, and the categories under which our brands are organised. Each area is dedicated to building sustainable solutions that will help us address the challenges presented by global mega-trends like urbanisation, climate change and digital transformation. These global pressures are challenging public health systems and increasing the need for improved hygiene products, services and education. We continuously innovate in areas like personalised nutrition, wellness, and digital health and hygiene so that individuals, families and communities can live cleaner, healthier lives.

Invatec

Invatec is a Bethlehem, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.